ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 186 filers reported holding ANI PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,305,190 | +20.9% | 22,480 | +12.1% | 0.00% | – |
| Q2 2023 | $1,079,454 | +7.7% | 20,053 | -20.5% | 0.00% | – |
| Q1 2023 | $1,002,254 | -1.3% | 25,233 | -0.0% | 0.00% | – |
| Q4 2022 | $1,015,244 | +97.5% | 25,236 | +57.8% | 0.00% | – |
| Q3 2022 | $514,000 | -2.8% | 15,991 | -10.3% | 0.00% | – |
| Q2 2022 | $529,000 | +54.2% | 17,836 | +46.2% | 0.00% | – |
| Q1 2022 | $343,000 | -23.4% | 12,198 | +25.3% | 0.00% | – |
| Q4 2021 | $448,000 | -5.9% | 9,733 | -32.9% | 0.00% | – |
| Q3 2021 | $476,000 | +76.3% | 14,501 | +88.0% | 0.00% | – |
| Q2 2021 | $270,000 | -45.6% | 7,713 | -43.8% | 0.00% | – |
| Q1 2021 | $496,000 | +237.4% | 13,724 | +169.6% | 0.00% | – |
| Q4 2020 | $147,000 | -66.9% | 5,090 | -67.6% | 0.00% | – |
| Q3 2020 | $444,000 | +60.9% | 15,729 | +83.9% | 0.00% | – |
| Q2 2020 | $276,000 | -18.6% | 8,551 | +2.7% | 0.00% | – |
| Q1 2020 | $339,000 | -13.7% | 8,328 | +30.7% | 0.00% | – |
| Q4 2019 | $393,000 | -68.4% | 6,373 | -62.7% | 0.00% | – |
| Q3 2019 | $1,245,000 | +75.6% | 17,084 | +98.1% | 0.00% | – |
| Q2 2019 | $709,000 | -22.8% | 8,622 | -33.7% | 0.00% | – |
| Q1 2019 | $918,000 | -40.9% | 13,009 | -62.3% | 0.00% | – |
| Q4 2018 | $1,554,000 | -28.3% | 34,505 | -10.0% | 0.00% | – |
| Q3 2018 | $2,168,000 | +442.0% | 38,355 | +541.2% | 0.00% | – |
| Q2 2018 | $400,000 | -22.2% | 5,982 | -32.3% | 0.00% | – |
| Q1 2018 | $514,000 | -14.0% | 8,833 | -5.0% | 0.00% | – |
| Q4 2017 | $598,000 | -53.3% | 9,298 | -61.9% | 0.00% | – |
| Q3 2017 | $1,281,000 | -66.0% | 24,387 | -69.7% | 0.00% | -100.0% |
| Q2 2017 | $3,771,000 | -61.4% | 80,585 | -59.1% | 0.00% | -50.0% |
| Q1 2017 | $9,764,000 | +2.5% | 197,224 | +25.5% | 0.00% | 0.0% |
| Q4 2016 | $9,525,000 | +60.0% | 157,113 | +75.1% | 0.00% | +100.0% |
| Q3 2016 | $5,952,000 | +28.9% | 89,707 | +8.4% | 0.00% | 0.0% |
| Q2 2016 | $4,619,000 | +82.9% | 82,752 | +10.3% | 0.00% | 0.0% |
| Q1 2016 | $2,525,000 | -14.9% | 74,998 | +14.0% | 0.00% | 0.0% |
| Q4 2015 | $2,968,000 | -1.3% | 65,781 | -13.6% | 0.00% | 0.0% |
| Q3 2015 | $3,008,000 | +258.1% | 76,133 | +462.7% | 0.00% | – |
| Q2 2015 | $840,000 | +140.0% | 13,529 | +142.3% | 0.00% | – |
| Q1 2015 | $350,000 | +9.7% | 5,583 | -1.3% | 0.00% | – |
| Q4 2014 | $319,000 | +838.2% | 5,655 | +372.0% | 0.00% | – |
| Q3 2014 | $34,000 | -82.0% | 1,198 | -78.2% | 0.00% | – |
| Q2 2014 | $189,000 | +0.5% | 5,498 | -8.7% | 0.00% | – |
| Q1 2014 | $188,000 | +93.8% | 6,025 | +24.5% | 0.00% | – |
| Q4 2013 | $97,000 | +106.4% | 4,840 | -0.3% | 0.00% | – |
| Q3 2013 | $47,000 | – | 4,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |